Hepatobiliary Surgery and Nutrition

Papers
(The TQCC of Hepatobiliary Surgery and Nutrition is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Ascites and complications: getting to the root of the trouble88
Short postoperative hospital stay after pancreaticoduodenectomy: what is real minimally invasive surgery?60
Donafenib as a first-line monotherapy for advanced hepatocellular carcinoma55
Right or left hepatectomy: a continuing question in the era of pure laparoscopic donor hepatectomy54
Can we talk about “futile surgery” for the upfront treatment of the perihilar cholangiocarcinoma?43
Adjuvant camrelizumab plus apatinib in resected hepatocellular carcinoma with microvascular invasion: a multi-center real world study35
A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact35
Advocating for the implementation of SonoVue microbubbles as pressure sensors: a call to action for clinical noninvasive pressure estimation32
Standardization is needed in reporting risk and outcomes of machine perfusion in liver transplantation30
A machine learning model for colorectal liver metastasis post-hepatectomy prognostications: several strategies for the model evaluation29
The application of real-time indocyanine green fluorescence cholangiography in laparoscopic living donor left lateral sectionectomy28
Surveillance of non-resected branch-duct intraductal papillary mucinous neoplasms: is a simplified algorithm justified?28
Future directions based on evaluation of long-term efficacy of total pancreatectomy and autologous islet transplantation28
The gut-liver axis links the associations between serum carotenoids and non-alcoholic fatty liver in a 7.8-year prospective study27
Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach24
Non-invasive liver disease assessments: can they replace liver biopsy?23
Where is the future of xenotransplantation headed?22
Emergent hybrid-dual-graft liver transplantation: a life-saving strategy for a patient with inadequate living donor graft during the COVID-19 pandemic17
Neoadjuvant therapy for resectable pancreatic cancers17
The use of thermal ablation in the treatment of colorectal liver metastasis—proper selection and application of technology17
Renewed considerations on the utility (or the futility) of hepatic resections for breast cancer liver metastases17
Does neoadjuvant therapy improve survival in pancreatic adenocarcinoma?15
Neuroendocrine liver metastases treatment strategies: a viewpoint15
The difficulty of medical decision-making: should patients be involved?15
Proposal of definition and diagnostic criteria for sarcopenic obesity by ESPEN and EASO14
Feasibility, safety and limits of robotic approach for lymphadenectomy in biliary tumours14
Surgical treatment of colorectal cancer liver metastases: individualized comprehensive treatment makes a difference14
Hepatic “pregnancy”: hepatocellular carcinoma with extensive extrahepatic growth13
Identification and treatment of biliary complications after liver transplantation: more relevant than ever13
Hepatic metastases in ovarian cancer13
Peri-hospital care: time to have a system for arranging patient care before and after hospitalization13
The portal-umbilical-iliac-systemic venous shunt in liver cirrhosis13
The ALPPS procedure—As Limited Procedures as Possible, leads to improved Survival12
More accurate reporting of surgical techniques would be SUPER12
International assessment and validation of the prognostic role of lymph node ratio in patients with resected pancreatic head ductal adenocarcinoma12
Intestinal autotransplantation: the next level of complexity in locally advanced pancreatic cancer12
A Japanese multi-institutional randomized controlled trial (ND-Trial)12
High volume transplant experience is beneficial but not mandatory for the performance of complex liver resections12
Treatment of portal vein thrombosis in cirrhosis with anticoagulation—more than meets the eye?11
Surgical decision-making: can patients benefit?11
Liver transplantation for non-resectable colorectal liver metastases11
Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?11
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis11
Slowly filling the gaps in our approach to diet and nutrition in inflammatory bowel diseases10
Microbial influence on liver regeneration: understanding gut microbiota and hepatic recovery post partial hepatectomy10
Comparable results of surgical versus non-surgical management for patients with malignant bowel obstruction—a lesson from S1316 study10
Global similarities: comparison of the Korean Liver Cancer Association chemoembolization guidelines for hepatocellular carcinoma to the National Comprehensive Cancer Network, American Association for 10
Resection post-radio-embolization in patients with single large hepatocellular carcinoma10
Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer10
Giant hepatic neuroendocrine tumor9
AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury: also useful for hepatobiliary surgeons9
Loco-regional treatments of unresectable hepatocellular carcinoma: safety first8
Prognostic significance of preoperative Naples prognostic score on short- and long-term outcomes after pancreatoduodenectomy for ampullary carcinoma8
Review of practice informing data and current state of NCCN consensus guidelines in hepatobiliary cancers8
Pancreatectomy with concomitant portal vein resection in the current neoadjuvant era8
Hype and hope of hepatic arterial infusion for colorectal cancer8
Xanthophyll β-cryptoxanthin treatment inhibits hepatic steatosis without altering vitamin A status in β-carotene 9',10'-oxygenase knockout mice8
Atezolizumab plus bevacizumab for patients with Child-Pugh-B in hepatocellular carcinoma7
The challenge of hepatic vein reconstruction in surgical oncology7
Electroacupuncture in liver regeneration: a Chinese traditional medicine approach to enhancing liver regeneration7
Does laparoscopic resection for colorectal cancer liver metastasis have a long-term oncologic advantage?7
Heterogeneity in the risk of incident liver cirrhosis driven by PNPLA3 genotype and diabetes among different populations7
Lean individuals with nonalcoholic fatty liver disease, the chicken or the egg?7
Conversion therapy for advanced cholangiocarcinoma in the era of molecular targeted therapy and immune therapy7
Radiofrequency ablation versus microwave ablation for colorectal liver metastases: long-term results of a retrospective cohort surgical experience7
Tailoring bacterial taxa for immune cell modulation7
The impact of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) on liver tumors with unusual indications7
The efforts are worth the benefits for laparoscopic liver resection7
New insights on portal hypertension’s screening in people with cystic fibrosis7
Is the exposure to liver transplantation worthwhile for trainees in liver surgery?6
Reply to: The letter to the editor “More details are needed about the use of multicenter propensity score matching analysis” by Feng et al.6
A new era for hepatocellular carcinoma6
Cholangiocarcinoma: a review of the literature and future directions in therapy6
Robotic pancreaticoduodenectomy after the learning curve—a new hope6
The Japanese Clinical Practice Guidelines for intrahepatic cholangiocarcinoma: a comparison with Western guidelines6
Age-specific microbiota in altering host inflammatory and metabolic signaling as well as metabolome based on the sex6
Impact of preoperative chemotherapy on surgical results in 139 patients with locally advanced pancreatic cancer6
Liver cirrhosis and sarcopenia: a dreadful combination6
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection6
Enhanced recovery after liver transplantation—a prospective analysis focusing on quality assessment6
The conclusion of reducing acute rejection after liver transplantation by machine perfusion should be extrapolated with caution6
East meets West: what opportunities arise in comparing international guidelines for management of cirrhosis?6
Exocrine pancreatic insufficiency: more compromise than precision5
Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer—the more the better?5
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma5
Fatty liver disease and risk of all cause and cause-specific mortality outcomes in the older population5
Association of Pringle maneuver with postoperative recurrence and survival following hepatectomy for hepatocellular carcinoma: a multicenter propensity score and competing-risks regression analysis5
3D laparoscopic anatomical hepatectomy guided by 2D real-time indocyanine green fluorescence imaging for hepatocellular carcinoma5
Managing portal hypertension in patients with liver cirrhosis and hepatocellular carcinoma: non-invasive diagnosis and systemic treatment considerations5
Impact of living donor liver with steatosis and idiopathic portal inflammation on clinical outcomes in pediatric liver transplantation: Beijing experience5
Choline suppresses hepatocellular carcinoma progression by attenuating AMPK/mTOR-mediated autophagy via choline transporter SLC5A7 activation5
Enhanced recovery for liver transplantation: recommendations from the 2022 International Liver Transplantation Society Consensus Conference: towards better clinical care in transplant hepatology5
Association of tumor morphology with long-term prognosis after liver resection for patients with a solitary huge hepatocellular carcinoma—a multicenter propensity score matching analysis5
Insights on liver-directed surgical innovations, targeted therapies, and immunotherapy for biliary tract cancer: navigating the new European Society for Medical Oncology (ESMO) Clinical Practice Guide5
Clinical utility of non-invasive tests to predict clinical outcomes in non-alcoholic fatty liver disease5
3D laparoscopy and fluorescence imaging can improve surgical precision for hepatectomy5
Breast cancer liver metastasis: time to resection and criteria4
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice4
Influence of immunosuppressive drugs on natural killer cells in therapeutic drug exposure in liver transplantation4
Obesity and its influence on liver dysfunction, morbidity and mortality after liver resection4
Simultaneous resection of synchronous colorectal liver metastases: a promising alternative to staged resections4
Prevalence and longitudinal effects on mortality associated with spectrum of alcohol intake in steatotic liver disease: a United States population study4
Evaluation of the economic impact of the robotic approach in major and postero-superior segment liver resections: a multicenter retrospective analysis4
Futibatinib: new targeted therapy in intrahepatic cholangiocarcinoma4
Guidelines on cholangioscopy for indeterminate biliary strictures: one step closer to consensus4
Highly variable biodistribution of 68Ga labeled somatostatin analogues 68Ga-DOTA-NOC and 68Ga-DOTA-TATE in neuroendocrine tumors: clinical implications for somatostatin receptor directed PET/CT4
High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection4
Expert consensus on magnetic recanalization technique for biliary anastomotic strictures after liver transplantation4
Characteristics and outcomes of hepatocellular carcinoma patients with macrovascular invasion following surgical resection: a meta-analysis of 40 studies and 8,218 patients4
Gallbladder volvulus4
Laparoscopic anatomical versus non-anatomical liver resection for hepatocellular carcinoma in the posterosuperior segments: a propensity score matched analysis4
Machine learning predicts unpredicted deaths with high accuracy following hepatopancreatic surgery4
Hepatocellular carcinoma in non-alcoholic fatty liver disease—a review of an emerging challenge facing clinicians4
Preoperative assessment of liver function and perioperative management of posthepatectomy liver failure4
Periprocedural management of hemostatic alterations in patients with cirrhosis and vascular liver disorders: a step forward of the American Association for the Study of Liver Diseases3
Liver venous deprivation (LVD) before extended hepatectomy: a French multicentric retrospective cohort3
The need for deepened molecular mechanism exploration in new onset diabetes after transplantation (NODAT)3
Pancreatic cancer screening in high-risk individuals with genetic susceptibility3
Comment on “Hypothermic machine perfusion in liver transplantation—a randomized trial”3
Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial3
Comment on: oncologic outcomes after robotic pancreatic resections are not inferior to open surgery3
Enhancing perioperative evaluation and abdominal drain in patients undergoing distal pancreatectomy3
Surgical Infection Society guidelines on antibiotic use in gallstone surgery: high time we crack down on prophylactic antibiotics3
Assessment of long-term graft function following total pancreatectomy and autologous islet transplantation: the Leicester experience3
An overview of the Chinese healthcare system3
Insights into treatment for hepatocellular carcinoma with tumor thrombus in the inferior vena cava or right atrium3
A 7-year-old girl with giant congenital biliary dilatation3
Multikinase inhibitor-based immunotherapy doublet for advanced hepatocellular carcinoma: its efficacy still needs to be determined3
Optimizing management of patients with pancreatic exocrine insufficiency3
Artificial intelligence and multi-omics driven models would be the future of intrahepatic cholangiocarcinoma prediction research3
Synchronous colorectal liver metastases: therapeutic considerations3
Molecular characterization of circulating tumor cells in pancreatic ductal adenocarcinoma: potential diagnostic and prognostic significance in clinical practice3
Comment on: Failure to rescue in patients with distal pancreatectomy: a nationwide analysis of 10,632 patients3
The Society for Immunotherapy of Cancer clinical practice guideline on immunotherapy for hepatocellular carcinoma3
Novel biomarkers and the future of targeted therapies in cholangiocarcinoma: a narrative review3
Intrahepatic portal vein variant: a single dilated intrahepatic portal vein coursing to the umbilical fissure without second-order branches3
Advances in 3D bioprinting technology for liver regeneration3
Advanced nonmetastatic hepatocellular carcinoma: curative surgery may be an option3
Chinese expert consensus on conversion therapy for hepatocellular carcinoma (2021 edition)3
Nonalcoholic steatohepatitis critically rewires the ischemia/reperfusion-induced dysregulation of cardiolipins and sphingolipids in mice3
The significance of severe postoperative complications on liver regeneration3
Integrative medicine and surgery: what are the diet and supplement recommendations for someone with pancreatic cancer?3
The German Transplant Certification3
Reply to the commentary on “The efficiency of pathological response after preoperative transcatheter arterial chemoembolization for microvascular invasion and early tumor recurrence in hepatocellular 3
Long-term outcomes in patients with non-alcoholic fatty liver disease: further evidence that a multidisciplinary and patient-centred approach to treatment is needed3
The vascular endothelial growth factor system—a new player in the pathogenesis and development of metabolic dysfunction- associated steatotic liver disease3
Same soup different taste—how to best manage the future liver remnant—a surgical perspective3
Determinants of prognosis in cirrhosis: a new outlook3
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent valid3
Erratum to classification of hepatic venous tumor thrombus in hepatocellular carcinoma: should it describe tumor status or predict patient survival?3
French Editorials from the Association de Chirurgie Hépato-Bilio-Pancréatique et Transplantation-France (ACHBPT)3
Acute coil migration in upper gastrointestinal bleeding3
Management of severe acute pancreatitis: all hands to the pump3
The global burden of fatty liver disease: the major impact of China3
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review3
Hepatic tuberculosis3
NAFLD or MAFLD: the data behind the debate3
The French guidelines for alcohol-related liver disease—what’s new, what’s not and what’s still needed3
Editorial on “Laparoscopic versus open liver resection for hepatocellular carcinoma in elderly patients: a propensity score matching analysis”2
Unravel hepatic artery infusion chemotherapy in patients with resected colorectal liver metastases2
Finding a role for cancer vaccines in pancreatic cancer: a model of resilience2
Comparison of alternative arterial anastomosis site during liver transplantation when the recipient’s hepatic artery is unusable2
Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care2
Dietitians’ role in obesity care: insights from the Academy of Nutrition and Dietetics2
Simultaneous portohepatic vein embolization a radiological: a short cut to associating liver partition and portal vein ligation for staged hepatectomy?2
Surgical resection of isolated pancreatic metastatic malignant melanoma2
Systemic treatment of hepatocellular carcinoma: the times they are a-changin’2
Evolocumab induced short-term biliary stent blockage and acute cholangitis in a jaundice patient with pancreatic carcinoma: a rare complication of PCSK9 inhibitor2
Alternatives to left lateral segment for pediatric liver transplantation, or required surgeon toolkit?2
The association between sarcopenia and cirrhosis: a Mendelian randomization analysis2
Roles of the human microbiome in cancer2
Understanding evidence-based clinical practice guidelines for cholelithiasis 20212
The potential role of associating liver partition and portal vein ligation in the treatment of colorectal liver metastases2
A journey of a thousand miles begins with one small step2
Eat more natural dietary fiber and whole grains to minimize liver disease risk2
Can metabolomic signature foster precision medicine approaches in nonalcoholic fatty liver disease arena?2
Are probiotics effective in reversing non-alcoholic steatohepatitis?2
Exploring treatment options for biliary tract cancers: moving beyond the era of gemcitabine and platinum doublet2
Semaglutide for nonalcoholic steatohepatitis: closer to a solution?2
Performance of major liver resection for gallbladder cancer—a western retrospective single center cohort study2
Beyond management to conquer life-threatening tumor thrombosis in hepatocellular carcinoma2
The power of prevention: how tenofovir and entecavir are changing the game in hepatocellular carcinoma2
The microbiome as a potential diagnostic biomarker for pancreatic ductal adenocarcinoma (PDAC)2
Early cholecystectomy cannot be regarded as a mortality risk factor in moderate and severe acute biliary pancreatitis2
Prognosis control surgery2
Enhancing diagnostic strategies for biliary strictures: an evolving landscape2
Comment on: “Impact of portable normothermic blood-based machine perfusion on outcomes of liver transplant: the OCS Liver PROTECT randomized clinical trial”2
Is immunotherapy-related liver injury more common in patients with hepatocellular carcinoma than in other advanced solid tumors?2
Prognostic impact of tumor marker kinetics and normalization during neoadjuvant chemotherapy for pancreatic cancer2
Pancreaticoduodenectomy: how to handle a replaced right hepatic artery2
Win ratio approach to compare laparoscopic with open liver resection for colorectal cancer liver metastases2
18F-fluorodeoxyglucose positron emission tomography/computed tomography in intrahepatic cholangiocarcinoma: could it be a new paradigm?2
The current application of thermal ablation in colorectal liver metastasis2
Proteome profiling to advance management of metabolic dysfunction-associated fatty liver disease2
Living donor liver transplantation combined with splenectomy in a child with Niemann-Pick disease type B: single-centre experience of perioperative anticoagulation regimen2
Management of decompensated liver cirrhosis in the surgical intensive care unit2
New developments in ablation therapy for hepatocellular carcinoma: combination with systemic therapy and radiotherapy2
A single center analysis of long-term outcomes and survival related risk factors in liver retransplantation2
Potential of extracellular vesicles and exosomes as diagnostic markers for cholangiocarcinoma2
Surgical management of metastatic neuroendocrine tumors: beyond the realm of evidence-based medicine2
Precision surgery with the genetic assessment for operable pancreatic cancer beyond the radiological assessment alone2
Extrahepatic organs in the development of non-alcoholic fatty liver disease in liver transplant patients2
Molecular pathology and protein markers for pancreatic cancer: relevance in staging, in adjuvant therapy, in determination of minimal residual disease, and follow-up2
Comment on: “Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study”2
Comparative associations of non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease with risk of incident chronic kidney disease: a cohort study2
Shrinking fat, healing liver: unlocking the metabolic dysfunction associated steatohepatitis puzzle2
Impact of adjuvant therapy on survival outcomes in resected gallbladder cancer: a systematic review and meta-analysis2
Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence2
Comment on “Perihilar cholangiocarcinoma—novel benchmark values for surgical and oncological outcomes from 24 expert centers”2
Enhancing prognostic insights in biliary atresia: implications of the iBALF score2
Exercise in the management of metabolic dysfunction-associated fatty liver disease—is more the answer, or is it just one piece of the puzzle?2
Robotic hepatectomy: challenge and progression2
Robotic liver surgery: should improving the safety and expanding the indication over laparoscopic liver surgery2
Beneficial effect of whole-grain wheat on liver fat: a role for the gut microbiota?2
Functional assessment of liver regeneration after major hepatectomy2
UDP-glucuronosyltransferases mediate coffee-associated reduction of liver fibrosis in bile duct ligated humanized transgenic UGT1A mice2
Assessment of morbidity and mortality after liver transplantation for primary sclerosing cholangitis2
0.0577712059021